Visudyne.com
  Novartis Pharma US

 
THE WORLD IS BEAUTIFUL > TO LOOK AT

Full Course of Therapy

The proper protocol for Visudyne therapy calls for a “full course of therapy.” This means treating patients every 3 months as long as leakage appears on fluorescein angiography.3 Two-year results from the TAP Investigation were achieved using this protocol, and Visudyne is indicated for use according to the same. (See TAP Protocol)

With Visudyne, patients must understand that successful therapy will require a commitment to several therapy sessions over time. Normally, the number of treatments per patient will vary, but studies show that, on average, patients require 2.7 treatments per year over the course of 2 years.2

Studies confirm that persistent therapy with Visudyne provides sustained efficacy.

In patients receiving Visudyne, visual benefit was sustained over 2 years.*2

2 Year Acuity Chart
* Patients receiving full course of therapy (every 3 months until leakage stopped) through 2 years of clinical studies.

Patients receiving the full course of therapy needed fewer treatments each year.2

Mean Nnumber of treatments per year
  • Course of therapy varied by individual angiographic response
  • Patients only received treatment at visits when leakage was present
Visudyne patients’ average number of treatments per 12-month period in the TAP Investigation and Extension, in eyes with predominantly classic CNV.

Home  |  Professional Main Page  |  About AMD
About Visudyne  |  Ordering Visudyne
Patient InSight Registry  |  Resources
Prescribing Information  |  Important Safety Information
Links  |  eSlide Library

Contact Us  |  Site Guide  |  Site Map
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access